Cargando…
Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?
SIMPLE SUMMARY: Immunotherapies have revolutionized the management of advanced stage cancer; however, not all patients benefit given many cancers are resistant to immune checkpoint inhibitors. To support rapid growth, malignant cells frequently bypass the cell cycle checkpoints that normally ensure...
Autores principales: | Goff, Peter H., Bhakuni, Rashmi, Pulliam, Thomas, Lee, Jung Hyun, Hall, Evan T., Nghiem, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307089/ https://www.ncbi.nlm.nih.gov/pubmed/34298632 http://dx.doi.org/10.3390/cancers13143415 |
Ejemplares similares
-
Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
por: Li, Yinuo, et al.
Publicado: (2023) -
From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation
por: Mouw, Kent W., et al.
Publicado: (2018) -
The Intra-S Checkpoint Responses to DNA Damage
por: Iyer, Divya Ramalingam, et al.
Publicado: (2017) -
Pneumocystis Pneumonia: Checkpoint Inhibition to the Rescue?
por: Better, Julian, et al.
Publicado: (2020) -
Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)